Funds advised by Permira Credit support CVC’s acquisition of Rayner, a leading global ophthalmology business14 January 2022
14 January 2022 – Permira Credit, one of Europe’s leading alternative credit providers, today announces that funds it advises are acting as sole senior secured lender to CVC Capital Partners’ acquisition of Rayner Surgical Group (“Rayner”). The support highlights Permira Credit’s focus on high-quality, growing businesses and builds on Permira’s proven track record of investing in the healthcare sector.
Founded in 1910, Rayner is a pioneering designer and manufacturer of advanced technology Intraocular Lenses (IOLs), delivering innovative and clinically superior ophthalmic products. Over its 100-year heritage in ophthalmology, which includes developing the world’s first IOL in 1949, Rayner has operated with a goal to improve vision and restore sight worldwide. The company has expanded its global manufacturing and commercial presence in recent years, making its products available in over 80 countries and helping more than 300,000 patients per year.
The Permira Credit funds are supporting Rayner’s acquisition of Omeros Corporation’s ophthalmology assets, including OmidriaTM. OmidriaTM has excellent and substantial clinical data supporting the maintenance of mydriasis (a dilated pupil) during surgery, protection of the eye from cystoid macular oedema and the reduction of post-operative pain without the use of opioids.
The acquisition will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products for cataract surgeons.